Titan Medical Inc
TSX:TMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (494), the stock would be worth CA$0.04 (6% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 524 | CA$0.05 |
0%
|
| 3-Year Average | 494 | CA$0.04 |
-6%
|
| 5-Year Average | 31.4 | CA$0 |
-94%
|
| Industry Average | 2.7 | CA$0 |
-99%
|
| Country Average | 2.9 | CA$0 |
-99%
|
Forward EV/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
|
Titan Medical Inc
TSX:TMD
|
686.5m CAD | 524 | -99.3 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
171.2B USD | 16.4 | 60 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
158.3B USD | 3.5 | 25.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.3B USD | 5.4 | 38.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106.9B USD | 3.6 | 23.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
92B USD | 4.9 | 25.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.9B USD | 7.2 | 44.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40B EUR | 2 | 19 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.1B USD | 10.6 | 42.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
43.3B USD | 2.7 | 24.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32B USD | 5.7 | 21.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.7 |
| Median | 2.9 |
| 70th Percentile | 5.7 |
| Max | 15 639 353.3 |
Other Multiples
Titan Medical Inc
Glance View
Titan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). The company is headquartered in Toronto, Ontario and currently employs 49 full-time employees. The company went IPO on 2008-04-28. The firm is developing its Enos system to become the new standard of care in robotic single access surgery, with dual three-dimensional (3D) and two-dimensional (2D) high-definition vision systems, multi-articulating instruments and an ergonomic surgeon workstation. Its multi-articulated instruments bring fluid to position the effectors for grasping, suturing, cutting and coagulation. The Enos surgeon workstation includes a 3D high-definition display to provide a balance of surgical immersion and situational awareness in the operating room.
